2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)

38  relevant articles (0 outcomes, 2 trials/studies) found for this Bio-Agent

2',3' Cyclic Nucleotide Phosphodiesterase; 2',3'-Cyclic Nucleotide Phosphodiesterase; 2',3'-Cyclic Nucleotide Phosphodiesterases; 2,3-Cyclic Nucleotide Phosphodiesterase; 2,3-Cyclic Nucleotide Phosphodiesterases; CNPase; 2',3' Cyclic Nucleotide Phosphodiesterases; 2,3 Cyclic Nucleotide Phosphodiesterase; 2,3 Cyclic Nucleotide Phosphodiesterases; Nucleotide Phosphodiesterase, 2',3'-Cyclic; Nucleotide Phosphodiesterase, 2,3-Cyclic; Nucleotide Phosphodiesterases, 2',3'-Cyclic; Nucleotide Phosphodiesterases, 2,3-Cyclic; Phosphodiesterase, 2',3'-Cyclic Nucleotide; Phosphodiesterase, 2,3-Cyclic Nucleotide; Phosphodiesterases, 2',3'-Cyclic Nucleotide; Phosphodiesterases, 2',3'-Cyclic-Nucleotide; Phosphodiesterases, 2,3-Cyclic Nucleotide

Bio-Agent Context: Research Results

Experts

1.	Afshar, G: 1 article (09/2002)
2.	Muraro, P A: 1 article (09/2002)
3.	McFarland, H F: 1 article (09/2002)
4.	Kalbus, M: 1 article (09/2002)
5.	Martin, R: 1 article (09/2002)
6.	Sulkowski, G: 1 article (06/2000)
7.	Struzyńska, L: 1 article (06/2000)
8.	Lenkiewicz, A: 1 article (06/2000)
9.	Dabrowska-Bouta, B: 1 article (06/2000)
10.	Walski, M: 1 article (06/2000)

Related Diseases

1.	Demyelinating Diseases (Demyelinating Disease) 06/01/1993 - "The correlation of the decrease in CNPase and MBP levels with the incidence of transient neurological malfunction and animal death, together with histological evidence, suggests that demyelination is responsible for these phenomena." 11/01/1990 - "CNPase was not decreased in its activity at 7 days, but decreased at 14 days, supporting progressive demyelination" 01/01/1986 - "It was considered that the reduction of CNPase activity and its recovery and increase reflect demyelination and activation of oligodendroglia for remyelination, respectively." 01/01/1984 - "We aimed to study the level of CNPase activity in the cerebrospinal fluid of patients with demyelinating diseases and other neurological diseases, particularly multiple sclerosis, with reference to CSF myelin basic protein content" 10/15/2004 - "This demyelination was observed by immunostaining for the myelin components myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG), and 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase)" Get all the results and reference details, order at left...
2.	Multiple Sclerosis 05/01/1997 - "Furthermore we describe for the first time several rh-CNPase specific T-cell lines from a multiple sclerosis patient and a healthy control." 12/01/1996 - "We have analysed the entire expressed sequence of the human CNPase gene in patients with multiple sclerosis and in healthy controls using single strand conformation polymorphism (SSCP) analysis" 01/01/1984 - "We concluded that CNPase activity in the cerebrospinal fluid from neurological patients is an indicator of destruction of myelin in the central nervous system, and the measurement of CNPase activity in the cerebrospinal fluid of multiple sclerosis could be useful in the clinical management." 01/01/1984 - "The level of CNPase activity in the cerebrospinal fluid of multiple sclerosis coincided with the clinical activity of the disease" 01/01/1984 - "Dividing the disease phases of multiple sclerosis into the three periods, the CNPase activity was found to be significantly elevated in the worsening period and reduced in the improving period and the inactive period" Get all the results and reference details, order at left...
3.	Paralysis (Palsy) 01/01/1992 - "This study showed that demyelination, as assessed by the levels of the myelin-associated proteins MBP and CNPase, can occur soon after spinal cord irradiation but that profound dose-dependent changes are seen only immediately preceding the onset of paralysis" 01/01/1990 - "The criteria for evaluation of the drug effect were changes in body weight, activity of 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNPase), clinical manifestations such as paralysis of lower extremities and histopathological changes" Get all the results and reference details, order at left...
4.	Body Weight (Weight, Body) 01/01/1987 - "Subjects were sacrificed at 60 days of age for measurement of brain and body weights, cerebral DNA content, and the activity of 2',3'-cyclic nucleotide phosphodiesterase (CNP), a myelin marker enzyme" 01/01/1990 - "The criteria for evaluation of the drug effect were changes in body weight, activity of 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNPase), clinical manifestations such as paralysis of lower extremities and histopathological changes" 01/01/1982 - "The body weight, liver weight, blood glucose, serum insulin and cerebral CNPase activity were decreased in alcoholic males" Get all the results and reference details, order at left...
5.	Infection 01/01/2007 - "CONCLUSIONS: The alteration of CNPase expression indicates that intrauterine infection could cause oligodendrocyte injury in the developing brain" 01/01/2005 - "The alteration of expression of GFAP, CNPase, and NF in the brain of neonatal rats after intrauterine infection suggested that intrauterine infection could cause neonatal white matter damage" 01/01/2005 - "In order to investigate the neuropathological effects on the developing rat brain after intrauterine infection, identification of glail fibrillary acidic protein (GFAP), 2', 3'-cyclic nucleotide phosphodiesterase (CNPase), and neurofilament (NF) was observed" 01/01/2007 - "AIMS: In order to investigate the neuropathological effect on the developing rat brain after intrauterine infection, 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) and inducible nitric oxide synthase (iNOS) were evaluated" Get all the results and reference details, order at left...
26 Diseases and 38 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	cyclic CMP phosphodiesterase
3.	Myelin-Associated Glycoprotein (S-MAG)
4.	Caspase 3 (Caspase-3)
5.	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
6.	Tubulin
7.	Ribonucleases (Ribonuclease)
8.	Polylysine
9.	Peptides
10.	Myelin Proteins
22 Drugs and Important Bio-Agents and 25 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Axotomy
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...